Cyclothiazide potentiates agonist responses at human AMPA/kainate receptors expressed in oocytes
- 1 January 1994
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 266 (1) , R1-R2
- https://doi.org/10.1016/0922-4106(94)90216-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainateJournal of Neuroscience, 1993
- Cyclothiazide Treatment Unmasks AMPA Excitotoxicity in Rat Primary Hippocampal CulturesJournal of Neurochemistry, 1993
- Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655European Journal of Pharmacology: Molecular Pharmacology, 1993
- A benzodiazepine recognition site associated with the non-NMDA glutamate receptorNeuron, 1993
- GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responsesNeuron, 1993
- Agonist- and subunit-dependent potentiation of glutamate receptors by a nootropic drug aniracetamMolecular Brain Research, 1992
- A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptorsNature, 1992
- Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466European Journal of Pharmacology, 1989